NCT04451044

Brief Summary

Multi-center, prospective, randomized controlled study comparing PCI guided by angiography versus iFR Co-Registration using commercially available Philips pressure guidewires and the SyncVision co-registration system, employing an adaptive design study for interim sample size re-estimation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,212

participants targeted

Target at P75+ for not_applicable coronary-artery-disease

Timeline
24mo left

Started Jun 2021

Longer than P75 for not_applicable coronary-artery-disease

Geographic Reach
17 countries

83 active sites

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Jun 2021Jun 2028

First Submitted

Initial submission to the registry

June 23, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 30, 2020

Completed
12 months until next milestone

Study Start

First participant enrolled

June 17, 2021

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Expected
Last Updated

January 20, 2025

Status Verified

January 1, 2025

Enrollment Period

5 years

First QC Date

June 23, 2020

Last Update Submit

January 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Major Adverse Cardiac Events (MACE; composite of cardiac death, target vessel MI (TVMI), or ischemia-driven revascularization) or hospitalization for progressive or unstable angina at 2 years

    2 years

Secondary Outcomes (9)

  • Major Adverse Cardiac Events (MACE; composite of cardiac death, target vessel MI (TVMI), or ischemia-driven revascularization) or hospitalization for progressive or unstable angina

    30 days, 1 year

  • All-cause, cardiac and non-cardiac mortality

    30 days, 1 year and 2 years

  • All MI, target vessel MI, non-target vessel MI, procedural MI, non-procedural MI

    30 days, 1 year and 2 years

  • Ischemia-driven revascularization, including all revascularization, TVR, TLR, non-TLR TVR, and non-TVR

    30 days, 1 year and 2 years

  • Hospitalization for progressive or unstable ischemia

    30 days, 1 year and 2 years

  • +4 more secondary outcomes

Study Arms (2)

physiologically-guided arm

EXPERIMENTAL

Physiologically-guided PCI using the Philips SyncVision system for determining the PCI strategy

Device: Philips SyncVision system with Philips pressure wires

angiographically-guided arm

ACTIVE COMPARATOR

Standard of care angiographically-guided PCI for determining the PCI strategy

Procedure: standard of care angiographically-guided PCI

Interventions

Intent to use physiologically-guided PCI using the Philips SyncVision system for determining the PCI strategy

physiologically-guided arm

Intent to use PCI standard of care angiographically-guided PCI for determining the PCI strategy

angiographically-guided arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Adult men and women (local age of consent) who present with stable or unstable angina, or NSTEMI.
  • \. Undergoing cardiac catheterization with planned PCI or possible ad hoc PCI
  • \. Following angiography, PCI is indicated in at least one coronary artery\* on the basis of one or more of the following:
  • Presenting with NSTE-ACS (unstable angina with ECG changes or cardiac enzyme-positive NSTEMI) with an identified culprit lesion with DS ≥50%;
  • One or more angiographic stenoses present with ≥80% stenosis severity by visual estimation;
  • One or more angiographic stenoses present with ≥50% to \<80% stenosis severity by visual estimation and an abnormal non-invasive stress test in the distribution of the lesion(s) within the past 60 days;
  • One or more angiographic stenoses are present with ≥50% to \<80% stenosis severity by visual estimation and a spot iFR measure ≤0.89 or FFR≤0.80 for borderline iFR..
  • Subject is willing to comply with all scheduled visits and tests and has provided informed written consent

You may not qualify if:

  • \. STEMI within 30 days
  • \. PCI within the prior 12 months, or any PCI planned after the study procedure (other than planned staged procedures of randomized vessels which are allowed)
  • \. Prior CABG anytime
  • \. Silent ischemia only (i.e. no cardiac symptoms related to coronary artery disease) within the prior 4 weeks
  • \. Documented prior iFR pullback performed in any coronary artery including during the qualifying diagnostic angiogram
  • \. Any vessel with in-stent restenosis (ISR) requiring treatment
  • \. Cardiogenic shock defined as systolic blood pressure \<90 mmHg for \>20 minutes not responding to fluid resuscitation, or need for inotropic, pressor, or device-based hemodynamic support
  • \. Presence of unstable ventricular arrhythmias
  • \. Heart rate \> 110, including uncontrolled atrial fibrillation (AF)
  • \. Decompensated congestive heart failure (NYHA Class IV or Killip Class III or IV)
  • \. Chronic total occlusion (CTO) of a target vessel (exception: a CTO may be present in a non-target vessel if it is supplying non-viable myocardium and there is no intent to open the CTO during the index or later procedure)
  • \. Coronary anatomy not amenable to pressure wire manipulation due to extreme tortuosity or complexity such that it is unlikely that a pressure wire could be passed to the distal third of the three major epicardial coronary arteries
  • \. Any angiographic giant thrombus (i.e., thrombus length \> 3x RVD at lesion)
  • \. Any target vessel with \< TIMI III flow
  • \. Any target lesion with a reference vessel diameter (RVD) less than 2.25mm except for within the side branch of a bifurcation lesion
  • +9 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (84)

University of Alabama Birmingham

Birmingham, Alabama, 35294, United States

Location

Pima Heart & Vascular

Tucson, Arizona, 85716, United States

Location

Central Arkansas Veterans Healthcare System (CAVHS)

Little Rock, Arkansas, 72205, United States

Location

Glendale Adventist

Glendale, California, 91206, United States

Location

Colorado Heart and Vascular

Lakewood, Colorado, 80228, United States

Location

Yale University

New Haven, Connecticut, 06520, United States

Location

MedStar Washington Hospital Center

Washington D.C., District of Columbia, 20010, United States

Location

Memorial Healthcare

Hollywood, Florida, 33201, United States

Location

Tampa Cardiovascular Innovations and Research

Tampa, Florida, 33607, United States

Location

Emory University Hospital

Atlanta, Georgia, 30322, United States

Location

Northeast Georgia Medical Center

Gainesville, Georgia, 30501, United States

Location

Straub Medical Center

Honolulu, Hawaii, 96813, United States

Location

Carle Foundation Hospital

Urbana, Illinois, 61801, United States

Location

Community Healthcare System

Munster, Indiana, 46321, United States

Location

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

Location

Mass General

Boston, Massachusetts, 02114, United States

Location

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

Metro Cardiology Consultants

Coon Rapids, Minnesota, 55433, United States

Location

Fairview Health Services

Edina, Minnesota, 55435, United States

Location

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

University of Nebraska Medical Center

Omaha, Nebraska, 68198, United States

Location

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, 03756, United States

Location

Gates Vascular Institute

Buffalo, New York, 14203, United States

Location

Northwell Health

Lake Success, New York, 11042, United States

Location

Columbia University Medical Center

New York, New York, 10032, United States

Location

St. Francis Hospital

Roslyn, New York, 11576, United States

Location

NC Heart and Vascular Research, LLC

Raleigh, North Carolina, 27607, United States

Location

Summa Health System

Akron, Ohio, 44304, United States

Location

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location

Bryn Mawr Hospital

Bryn Mawr, Pennsylvania, 19010, United States

Location

Jefferson Einstein Medical Center

Philadelphia, Pennsylvania, 19141, United States

Location

UPMC Presbyterian

Pittsburgh, Pennsylvania, 15213, United States

Location

Lankenau Medical Center

Wynnewood, Pennsylvania, 19096, United States

Location

North Central Heart

Sioux Falls, South Dakota, 57108, United States

Location

Centennial Medical Center

Nashville, Tennessee, 37203, United States

Location

Ascension Saint Thomas

Nashville, Tennessee, 37205, United States

Location

Baylor Scott & White, The Heart Hospital Plano

Plano, Texas, 75093, United States

Location

Sentara Health

Norfolk, Virginia, 23502, United States

Location

Carilion Clinic

Roanoke, Virginia, 24014, United States

Location

Gundersen Health

La Crosse, Wisconsin, 54601, United States

Location

Gosford Hospital

Gosford, New South Wales, Australia

Location

Liverpool Hospital

Liverpool, New South Wales, Australia

Location

Royal North Shore Hospital

Saint Leonards, New South Wales, Australia

Location

Prince of Wales Hospital

Sydney, New South Wales, Australia

Location

Lake Macquarie Private Hospital

Gateshead, Australia

Location

The Alfred Hospital

Melbourne, Australia

Location

Akademisches Lehrkrankenhaus Feldkirch

Feldkirch, Austria

Location

Royal Columbian Hospital

New Westminster, British Columbia, Canada

Location

Montreal Heart Institute

Montreal, Quebec, Canada

Location

William Osler Health-Brampton Civic Hospital

Brampton, Canada

Location

Hopital du Sacre-Coeur de Montreal

Montreal, Canada

Location

St. Michael's Hospital

Toronto, Canada

Location

Aarhus University Hospital

Aarhus, Denmark

Location

CHU Lille, Institut Coeur Poumon

Lille, France

Location

CHU Nimes Caremeau

Nîmes, France

Location

Vivantes Klinikum im Friedrichshain

Berlin, 10249, Germany

Location

Erlangen University Hospital

Erlangen, Germany

Location

University Hospital Essen

Essen, Germany

Location

Universitsklinik Freiburg

Freiburg im Breisgau, Germany

Location

Hillel Yaffe Medical Center

Hadera, Israel

Location

Shamir Medical Center

Tel Aviv, Israel

Location

Careggi University Hospital

Florence, Italy

Location

Hospital General Querétaro

Querétaro, Mexico

Location

Albert Schweitzer Ziekenhuis / Hartcentum Dordrecht- Gorinchem

Dordrecht, Netherlands

Location

Medisch Spectrum Twente

Enschede, Netherlands

Location

Medisch Centrum Leeuwarden

Leeuwarden, Netherlands

Location

St Antonius Hospital Nieuwegein

Nieuwegein, Netherlands

Location

Radboud University Med Ctr

Nijmegen, Netherlands

Location

Medical University of Warsaw

Warsaw, Poland

Location

Hospital Prof. Doutour Fernando Foneseca

Amadora, Portugal

Location

Sejong General Hospital

Bucheon-si, South Korea

Location

Keimyung University Dongsan Medical Center

Daegu, South Korea

Location

Seoul National University Hospital

Seoul, South Korea

Location

Hospital Universitario Reina Sofía

Córdoba, Spain

Location

Hospital Universitario de Leon

León, Spain

Location

Hospital Clinico San Carlos

Madrid, Spain

Location

Hospital Universitario Marqués de Valdecillas

Santander, Spain

Location

Skane University Hospital

Lund, Sweden

Location

Örebro University Hospital

Örebro, Sweden

Location

Geneva University Hospital

Geneva, Switzerland

Location

University Hospital Southampton

Southampton, Hampshire, S016 6YD, United Kingdom

Location

University Hospital of Wales

Cardiff, Wales, United Kingdom

Location

Royal Bournemouth Hospital

Bournemouth, United Kingdom

Location

Imperial College Healthcare NHS Trust

London, United Kingdom

Location

MeSH Terms

Conditions

Coronary Artery DiseaseMyocardial Ischemia

Condition Hierarchy (Ancestors)

Coronary DiseaseHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Allen Jeremias, MD MSC FACC FSCAI

    Saint Francis Hospital

    PRINCIPAL INVESTIGATOR
  • Gregg W Stone, MD

    The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2020

First Posted

June 30, 2020

Study Start

June 17, 2021

Primary Completion

June 1, 2026

Study Completion (Estimated)

June 1, 2028

Last Updated

January 20, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations